Review



human ift88  (Vector Biolabs)


Bioz Verified Symbol Vector Biolabs is a verified supplier
Bioz Manufacturer Symbol Vector Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Biolabs human ift88
    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) <t>IFT88</t> knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    Human Ift88, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 356 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ift88/product/Vector Biolabs
    Average 96 stars, based on 356 article reviews
    human ift88 - by Bioz Stars, 2026-04
    96/100 stars

    Images

    1) Product Images from "Primary cilia regulate GLP-1 signaling in pancreatic β cells"

    Article Title: Primary cilia regulate GLP-1 signaling in pancreatic β cells

    Journal: bioRxiv

    doi: 10.64898/2026.02.22.707280

    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) IFT88 knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    Figure Legend Snippet: ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) IFT88 knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.

    Techniques Used: Knock-Out, Knockdown, Transduction, Control, shRNA, Incubation

    ( A ) Representative z-projected confocal images of human islets (28-year-old female donor) transduced with scrambled (Scr) or IFT88 -targeting shRNA adenovirus. GFP (green) marks transduced cells; ARL13B (red) labels primary cilia; DAPI (blue) stains nuclei. Scale bar = 20 µm. Cilia length was quantified from both conditions, showing significantly reduced mean length following IFT88 knockdown. n=132 cilia from 6 islets (Scr shRNA) and 467 cilia from 8 islets (IFT88 shRNA). ( B–C ) IFT88 knockdown efficiency was assessed across multiple donors to demonstrate reproducibility. ( B ) qPCR analysis of IFT88 mRNA levels in islets from two male donors (ages 27 and 44). ( C ) Immunoblot analysis of IFT88 protein levels in islets from three male donors (ages 36, 49 and 45), with corresponding quantifications. Bars represent scrambled control (gray) and IFT88 shRNA (pink). Data are mean ± SEM of duplicate or triplicate samples per donor. **p < 0.01, ****p < 0.0001, ns = not significant, by student’s unpaired t-test.
    Figure Legend Snippet: ( A ) Representative z-projected confocal images of human islets (28-year-old female donor) transduced with scrambled (Scr) or IFT88 -targeting shRNA adenovirus. GFP (green) marks transduced cells; ARL13B (red) labels primary cilia; DAPI (blue) stains nuclei. Scale bar = 20 µm. Cilia length was quantified from both conditions, showing significantly reduced mean length following IFT88 knockdown. n=132 cilia from 6 islets (Scr shRNA) and 467 cilia from 8 islets (IFT88 shRNA). ( B–C ) IFT88 knockdown efficiency was assessed across multiple donors to demonstrate reproducibility. ( B ) qPCR analysis of IFT88 mRNA levels in islets from two male donors (ages 27 and 44). ( C ) Immunoblot analysis of IFT88 protein levels in islets from three male donors (ages 36, 49 and 45), with corresponding quantifications. Bars represent scrambled control (gray) and IFT88 shRNA (pink). Data are mean ± SEM of duplicate or triplicate samples per donor. **p < 0.01, ****p < 0.0001, ns = not significant, by student’s unpaired t-test.

    Techniques Used: Transduction, shRNA, Knockdown, Western Blot, Control



    Similar Products

    96
    Vector Biolabs human ift88
    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) <t>IFT88</t> knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    Human Ift88, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ift88/product/Vector Biolabs
    Average 96 stars, based on 1 article reviews
    human ift88 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-human ift88 antibody
    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) <t>IFT88</t> knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    Rabbit Anti Human Ift88 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human ift88 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit anti-human ift88 antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Ribobio co sirna targeting human ift88
    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) <t>IFT88</t> knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    Sirna Targeting Human Ift88, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sirna targeting human ift88/product/Ribobio co
    Average 90 stars, based on 1 article reviews
    sirna targeting human ift88 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    92
    Addgene inc g human pgk promoter
    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) <t>IFT88</t> knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.
    G Human Pgk Promoter, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/g human pgk promoter/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    g human pgk promoter - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    90
    Thermo Fisher sirna targeting human ift88
    IFT88 downregulation increases maturation marker expression with attenuating proliferation activity. (A) cDCs were stimulated with 1 μg/mL Df for 48 h. After immunostaining of acetylated tubulin, the percentage of primary ciliated cells was determined. n = 10 biological replicates (10 donors). The number of observed cells and primary cilium are as follows: no treatment; 8 cilia/1,074 cells. Df; 17 cilia/1,055 cells. The bar indicates the median value. **, p < 0.01 (Mann-Whitney U test). (B) cDCs were stimulated with 1 <g/mL LPS for 24 h. After immunostaining of acetylated tubulin, primary ciliated cDCs were counted and their numbers graphed. n = 15 biological replicates (15 donors). The number of observed cells and primary cilium are as follows: no treatment; 13 cilia/1,679 cells. LPS; 7 cilia/1687 cells. The bar indicates the median rate. *, p < 0.05, Mann-Whitney U test. (C) Five thousand cDCs were stimulated with 1 μg/mL Df for 48 h, then the cell number was calculated by the CCK8/WST-1 assay. To generate the calibration curve, the absorbance values of 3,000, 5,000, and 10,000 cells were measured. Cell numbers in each sample were calculated from the standard curve. Relative cell numbers were calculated by dividing by the untreated sample value. The bar indicates the median value. The Mann-Whitney U test was performed. n = 11 biological replicates (11 donors). (D) Five thousand cDCs were stimulated with 1 μg/mL LPS for 48 h, then relative cell numbers were calculated by performing the CCK8/WST-1 assay. The bar indicates the median value. The Mann Whitney U test was performed. n = 12 biological replicates (12 donors). (E) Five thousand cDCs were stimulated with 10 ng/mL PDGF-A or 10 ng/ml GM-CSF for 48 h. Relative numbers of cDCs were determined by the CCK8/WST-1 assay. For the negative control of PDGF-A stimulation, PDGF-A solvent (4 mM HCl, 0.1% BSA) was added. The bar indicates the median value. Kruskal-Wallis and Dunn’s multiple comparison was used for statistical analysis. *, p < 0.05, **, p < 0.01, n = 15 biological replicates (15 donors). (F) Representative expression of maturation markers in DCs. To differentiate immature DCs, THP1 cells were cultured with 100 ng/ml GM-CSF and 100 ng/mL IL-4 for 5 days. On day 5, cells <t>were</t> <t>electroporated</t> with 20 nM <t>siRNA</t> targeting IFT88 or control siRNA. Two days after electroporation, the expression of cell markers was analyzed by flow cytometry. n = 3 biological replicates. (G) Representative image of IFT88 in THP1-derived immature DC detected by Western blotting. n = 3 biological replicates (3 donors). (H) Immature DCs derived from THP1 were electroporated with 20 nM siRNA. Two days after electroporation, 5,000 cells were stimulated with 10 ng/mL PDGF-A or 10 ng/ml GM-CSF for 48 h. A CCK8/WST-1 assay was performed to calculate the cell number. The bar indicates the median value. **, p < 0.01 (one-way ANOVA, Tukey’s multiple comparison). n = 5 biological replicates.
    Sirna Targeting Human Ift88, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sirna targeting human ift88/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    sirna targeting human ift88 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti human ift88
    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein <t>IFT88.</t> **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).
    Rabbit Anti Human Ift88, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human ift88/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti human ift88 - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti human intraflagellar transport 88 ift88 antibody
    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein <t>IFT88.</t> **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).
    Rabbit Anti Human Intraflagellar Transport 88 Ift88 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human intraflagellar transport 88 ift88 antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti human intraflagellar transport 88 ift88 antibody - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    Thermo Fisher silencer select predesigned sirnas against human ift88
    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein <t>IFT88.</t> **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).
    Silencer Select Predesigned Sirnas Against Human Ift88, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/silencer select predesigned sirnas against human ift88/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    silencer select predesigned sirnas against human ift88 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    91
    OriGene size 10 211 bp pift88
    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein <t>IFT88.</t> **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).
    Size 10 211 Bp Pift88, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/size 10 211 bp pift88/product/OriGene
    Average 91 stars, based on 1 article reviews
    size 10 211 bp pift88 - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti human ift88 polyclonal antibody
    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein <t>IFT88.</t> **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).
    Rabbit Anti Human Ift88 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human ift88 polyclonal antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti human ift88 polyclonal antibody - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) IFT88 knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.

    Journal: bioRxiv

    Article Title: Primary cilia regulate GLP-1 signaling in pancreatic β cells

    doi: 10.64898/2026.02.22.707280

    Figure Lengend Snippet: ( A ) Dynamic insulin secretion from perifused mouse islets. Wild-type (WT, black) and β-cell-specific cilia knockout (βCKO, red) islets were sequentially exposed to 2 mM glucose (2G), 16 mM glucose (16G), 20 nM liraglutide (Lira), and 30 mM KCl as indicated. N = 6 replicates of 50 islets per genotype from 5 mice. *p<0.05, two-way ANOVA with Sidak’s multiple comparisons test. ( B–D ) Quantitative analysis of secretion traces. ( B ) Area under the curve (AUC) during liraglutide stimulation (minutes 30–50). ( C ) Total AUC of the entire perifusion (minutes 0-70). ( D ) AUC during KCl depolarization (minutes 60–70). βCKO islets secreted significantly less insulin in response to liraglutide and overall but showed no defect in KCl-induced secretion. Data are mean ± SEM. **p<0.01; ns, not significant, unpaired student’s t-test. ( E–J ) IFT88 knockdown impairs GLP-1-augmented secretion in human islets. Static glucose-stimulated insulin secretion (GSIS) assays from islets of male ( E–G ) and female ( H–J ) donors. Islets transduced with control (Ctl, white) or IFT88 -targeting shRNA (IFT88 KD, red) were incubated at 1 mM glucose (1G), 11 mM glucose (11G), and 11G + 100 nM liraglutide (Lira). Donor ages are indicated. IFT88 KD significantly reduced liraglutide-potentiated insulin secretion. Data are mean ± SEM of triplicate samples per donor. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; ns, not significant; one-way ANOVA with Tukey’s multiple comparisons test.

    Article Snippet: IFT88 knockdown in human islets: Healthy non-diabetic human islets were transduced with adenoviral vectors encoding either GFP-tagged shRNA targeting human IFT88 (Ad-GFP-h-IFT88-shRNA) or scrambled control (Ad-GFP-U6-scrmb-shRNA, #1122N; Vector Biolabs).

    Techniques: Knock-Out, Knockdown, Transduction, Control, shRNA, Incubation

    ( A ) Representative z-projected confocal images of human islets (28-year-old female donor) transduced with scrambled (Scr) or IFT88 -targeting shRNA adenovirus. GFP (green) marks transduced cells; ARL13B (red) labels primary cilia; DAPI (blue) stains nuclei. Scale bar = 20 µm. Cilia length was quantified from both conditions, showing significantly reduced mean length following IFT88 knockdown. n=132 cilia from 6 islets (Scr shRNA) and 467 cilia from 8 islets (IFT88 shRNA). ( B–C ) IFT88 knockdown efficiency was assessed across multiple donors to demonstrate reproducibility. ( B ) qPCR analysis of IFT88 mRNA levels in islets from two male donors (ages 27 and 44). ( C ) Immunoblot analysis of IFT88 protein levels in islets from three male donors (ages 36, 49 and 45), with corresponding quantifications. Bars represent scrambled control (gray) and IFT88 shRNA (pink). Data are mean ± SEM of duplicate or triplicate samples per donor. **p < 0.01, ****p < 0.0001, ns = not significant, by student’s unpaired t-test.

    Journal: bioRxiv

    Article Title: Primary cilia regulate GLP-1 signaling in pancreatic β cells

    doi: 10.64898/2026.02.22.707280

    Figure Lengend Snippet: ( A ) Representative z-projected confocal images of human islets (28-year-old female donor) transduced with scrambled (Scr) or IFT88 -targeting shRNA adenovirus. GFP (green) marks transduced cells; ARL13B (red) labels primary cilia; DAPI (blue) stains nuclei. Scale bar = 20 µm. Cilia length was quantified from both conditions, showing significantly reduced mean length following IFT88 knockdown. n=132 cilia from 6 islets (Scr shRNA) and 467 cilia from 8 islets (IFT88 shRNA). ( B–C ) IFT88 knockdown efficiency was assessed across multiple donors to demonstrate reproducibility. ( B ) qPCR analysis of IFT88 mRNA levels in islets from two male donors (ages 27 and 44). ( C ) Immunoblot analysis of IFT88 protein levels in islets from three male donors (ages 36, 49 and 45), with corresponding quantifications. Bars represent scrambled control (gray) and IFT88 shRNA (pink). Data are mean ± SEM of duplicate or triplicate samples per donor. **p < 0.01, ****p < 0.0001, ns = not significant, by student’s unpaired t-test.

    Article Snippet: IFT88 knockdown in human islets: Healthy non-diabetic human islets were transduced with adenoviral vectors encoding either GFP-tagged shRNA targeting human IFT88 (Ad-GFP-h-IFT88-shRNA) or scrambled control (Ad-GFP-U6-scrmb-shRNA, #1122N; Vector Biolabs).

    Techniques: Transduction, shRNA, Knockdown, Western Blot, Control

    IFT88 downregulation increases maturation marker expression with attenuating proliferation activity. (A) cDCs were stimulated with 1 μg/mL Df for 48 h. After immunostaining of acetylated tubulin, the percentage of primary ciliated cells was determined. n = 10 biological replicates (10 donors). The number of observed cells and primary cilium are as follows: no treatment; 8 cilia/1,074 cells. Df; 17 cilia/1,055 cells. The bar indicates the median value. **, p < 0.01 (Mann-Whitney U test). (B) cDCs were stimulated with 1 <g/mL LPS for 24 h. After immunostaining of acetylated tubulin, primary ciliated cDCs were counted and their numbers graphed. n = 15 biological replicates (15 donors). The number of observed cells and primary cilium are as follows: no treatment; 13 cilia/1,679 cells. LPS; 7 cilia/1687 cells. The bar indicates the median rate. *, p < 0.05, Mann-Whitney U test. (C) Five thousand cDCs were stimulated with 1 μg/mL Df for 48 h, then the cell number was calculated by the CCK8/WST-1 assay. To generate the calibration curve, the absorbance values of 3,000, 5,000, and 10,000 cells were measured. Cell numbers in each sample were calculated from the standard curve. Relative cell numbers were calculated by dividing by the untreated sample value. The bar indicates the median value. The Mann-Whitney U test was performed. n = 11 biological replicates (11 donors). (D) Five thousand cDCs were stimulated with 1 μg/mL LPS for 48 h, then relative cell numbers were calculated by performing the CCK8/WST-1 assay. The bar indicates the median value. The Mann Whitney U test was performed. n = 12 biological replicates (12 donors). (E) Five thousand cDCs were stimulated with 10 ng/mL PDGF-A or 10 ng/ml GM-CSF for 48 h. Relative numbers of cDCs were determined by the CCK8/WST-1 assay. For the negative control of PDGF-A stimulation, PDGF-A solvent (4 mM HCl, 0.1% BSA) was added. The bar indicates the median value. Kruskal-Wallis and Dunn’s multiple comparison was used for statistical analysis. *, p < 0.05, **, p < 0.01, n = 15 biological replicates (15 donors). (F) Representative expression of maturation markers in DCs. To differentiate immature DCs, THP1 cells were cultured with 100 ng/ml GM-CSF and 100 ng/mL IL-4 for 5 days. On day 5, cells were electroporated with 20 nM siRNA targeting IFT88 or control siRNA. Two days after electroporation, the expression of cell markers was analyzed by flow cytometry. n = 3 biological replicates. (G) Representative image of IFT88 in THP1-derived immature DC detected by Western blotting. n = 3 biological replicates (3 donors). (H) Immature DCs derived from THP1 were electroporated with 20 nM siRNA. Two days after electroporation, 5,000 cells were stimulated with 10 ng/mL PDGF-A or 10 ng/ml GM-CSF for 48 h. A CCK8/WST-1 assay was performed to calculate the cell number. The bar indicates the median value. **, p < 0.01 (one-way ANOVA, Tukey’s multiple comparison). n = 5 biological replicates.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Dendritic cell proliferation by primary cilium in atopic dermatitis

    doi: 10.3389/fmolb.2023.1149828

    Figure Lengend Snippet: IFT88 downregulation increases maturation marker expression with attenuating proliferation activity. (A) cDCs were stimulated with 1 μg/mL Df for 48 h. After immunostaining of acetylated tubulin, the percentage of primary ciliated cells was determined. n = 10 biological replicates (10 donors). The number of observed cells and primary cilium are as follows: no treatment; 8 cilia/1,074 cells. Df; 17 cilia/1,055 cells. The bar indicates the median value. **, p < 0.01 (Mann-Whitney U test). (B) cDCs were stimulated with 1

    Article Snippet: After 5 days of differentiation, cells were electroporated with 20 nM siRNA targeting human IFT88 (Life Technologies), or siRNA Control (AM4611, Invitrogen) with the Neon Transfection System (Thermo Fisher Scientific).

    Techniques: Marker, Expressing, Activity Assay, Immunostaining, MANN-WHITNEY, WST-1 Assay, Negative Control, Solvent, Comparison, Cell Culture, Control, Electroporation, Flow Cytometry, Derivative Assay, Western Blot

    Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein IFT88. **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).

    Journal: Acta Protozoologica

    Article Title: The function of ciliopathy protein FOP on cilia and cortical microtubule cytoskeleton in Euplotes amieti

    doi: 10.4467/16890027ap.23.005.18868

    Figure Lengend Snippet: Figure 3. Protein loss and motility changes after RNAi. (A) Relative expression of basal body-associated protein BBS8. **P < 0.01 vs the blank group, n = 3. (B) Relative expression of cilia assembly-related protein IFT88. **P < 0.01 vs the blank group, n = 3. (C) Relative expression of basal body protein γ-tubulin. (D) The swimming tracks of Euplotes amieti during RNAi. The swimming speeds (n = 20). The FOPRNAi is the interference group, The Blank is the blank group (E) The swimming speeds of Euplotes amieti during RNAi (n = 20).

    Article Snippet: Subsequently, the membranes were blocked in TBST buffer with 1 % skimmed milk for 2 hours at RT and respectively incubated with rabbit anti-human FOP (1:2000, Proteintech, China), rabbit anti-human β-tubulin (1:10000, Abcam, USA), rabbit anti-human BBS8 (1:500, Proteintech, China), rabbit anti-human IFT88 (1:1500, Proteintech, China), mouse anti-human γ-tubulin (1:10000, Sigma-Aldrich, USA), rabbit anti-human β-actin (1:10000, Proteintech, China) overnight at 4 °C, followed by peroxidase-conjugated sheep anti-rabbit/ mouse IgG secondary antibody (1:2000, Thermo Fisher Scientific, USA) for 2 hours at RT, respectively.

    Techniques: Expressing